Patents by Inventor Ghassan M. Saed

Ghassan M. Saed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods to treat solid tumors
    Patent number: 11180560
    Abstract: Compositions and methods that utilize anti-CD11b antibodies, anti-CD18 antibodies, anti-myeloperoxidase (MPO) antibodies, anti-integrin ?V antibodies, anti-integrin ?1 antibodies, Abciximab, neutrophil inhibitory factor (NIF) protein, and/or combinations thereof to treat solid tumors are described.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: November 23, 2021
    Assignee: Wayne State University
    Inventor: Ghassan M. Saed
  • COMPOSITIONS AND METHODS TO TREAT SOLID TUMORS
    Publication number: 20190309073
    Abstract: Compositions and methods that utilize anti-CD11b antibodies, anti-CD18 antibodies, anti-myeloperoxidase (MPO) antibodies, anti-integrin ?V antibodies, anti-integrin ?1 antibodies, Abciximab, neutrophil inhibitory factor (NIF) protein, and/or combinations thereof to treat solid tumors are described.
    Type: Application
    Filed: May 20, 2019
    Publication date: October 10, 2019
    Applicant: Wayne State University
    Inventor: Ghassan M. Saed
  • Compositions and methods to treat solid tumors
    Patent number: 10336827
    Abstract: Compositions and methods that utilize anti-CD11b antibodies, anti-CD18 antibodies, anti-myeloperoxidase (MPO) antibodies, anti-integrin ?V antibodies, anti-integrin ?1 antibodies, Abciximab, neutrophil inhibitory factor (NIF) protein, and/or combinations thereof to treat solid tumors are described.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: July 2, 2019
    Assignee: Wayne State University
    Inventor: Ghassan M. Saed
  • COMPOSITIONS AND METHODS TO TREAT SOLID TUMORS
    Publication number: 20170121410
    Abstract: Compositions and methods that utilize anti-CD11b antibodies, anti-CD18 antibodies, anti-myeloperoxidase (MPO) antibodies, anti-integrin ?V antibodies, anti-integrin ?1 antibodies, Abciximab, neutrophil inhibitory factor (NIF) protein, and/or combinations thereof to treat solid tumor cancers are described.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Applicant: WAYNE STATE UNIVERSITY
    Inventor: Ghassan M. Saed
  • Method of preventing adhesions by apoptosis of adhesion peritoneal cells
    Publication number: 20040131600
    Abstract: Methods for the prevention of adhesion formation and development involve the administration of therapeutic formulations to a patient which modulates the rate of apoptosis of adhesion fibroblast cells. The formulations preferably include Bax, Bax enhancers, such as p53, Bax agonists, Bcl-2 inhibitors and Bcl-2 antagonists. A method is also provided for determining the predisposition of a subject to adhesion formation by measuring the Bcl-2/Bax ratio at multiple sites within the subject.
    Type: Application
    Filed: March 1, 2004
    Publication date: July 8, 2004
    Inventors: Michael P. Diamond, Ghassan M Saed
  • Model for in vitro adhesion development
    Publication number: 20040096817
    Abstract: A biological model for the development of adhesions in vitro comprises a pair of opposed surfaces of tissue explants maintained in a culture media for a sufficient time and under conditions to permit the formation of adhesions. The model is useful for evaluating compounds and techniques for the prevention and remediation of adhesions, and for individualizing the therapeutic options for patients who may experience adhesions.
    Type: Application
    Filed: May 28, 2003
    Publication date: May 20, 2004
    Applicant: Wayne State University
    Inventors: Michael P. Diamond, Ghassan M. Saed